BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17091221)

  • 1. Identification and characterization of different SHOX gene deletions in patients with Leri-Weill dyschondrosteosys by MLPA assay.
    Gatta V; Antonucci I; Morizio E; Palka C; Fischetto R; Mokini V; Tumini S; Calabrese G; Stuppia L
    J Hum Genet; 2007; 52(1):21-27. PubMed ID: 17091221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duplications upstream and downstream of SHOX identified as novel causes of Leri-Weill dyschondrosteosis or idiopathic short stature.
    Bunyan DJ; Baffico M; Capone L; Vannelli S; Iughetti L; Schmitt S; Taylor EJ; Herridge AA; Shears D; Forabosco A; Coviello DA
    Am J Med Genet A; 2016 Apr; 170A(4):949-57. PubMed ID: 26698168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of MLPA in the detection of SHOX deletions.
    Funari MF; Jorge AA; Souza SC; Billerbeck AE; Arnhold IJ; Mendonca BB; Nishi MY
    Eur J Med Genet; 2010; 53(5):234-8. PubMed ID: 20538086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of cryptic SHOX intragenic deletions in three Japanese patients with Léri-Weill dyschondrosteosis.
    Fukami M; Dateki S; Kato F; Hasegawa Y; Mochizuki H; Horikawa R; Ogata T
    J Hum Genet; 2008; 53(5):454-459. PubMed ID: 18322641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostics of SHOX gene rearrangement in 46,XX women with idiopathic short stature.
    Mitka M; Bednarek M; Kałużewski B
    Endokrynol Pol; 2016; 67(4):397-402. PubMed ID: 27387244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular evaluation of SHOX/PAR1 duplications in Leri-Weill dyschondrosteosis (LWD) and idiopathic short stature (ISS).
    Benito-Sanz S; Barroso E; Heine-Suñer D; Hisado-Oliva A; Romanelli V; Rosell J; Aragones A; Caimari M; Argente J; Ross JL; Zinn AR; Gracia R; Lapunzina P; Campos-Barros A; Heath KE
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E404-12. PubMed ID: 21147883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancer deletions of the SHOX gene as a frequent cause of short stature: the essential role of a 250 kb downstream regulatory domain.
    Chen J; Wildhardt G; Zhong Z; Röth R; Weiss B; Steinberger D; Decker J; Blum WF; Rappold G
    J Med Genet; 2009 Dec; 46(12):834-9. PubMed ID: 19578035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptic intragenic deletion of the SHOX gene in a family with Léri-Weill dyschondrosteosis detected by Multiplex Ligation-Dependent Probe Amplification (MLPA).
    Funari MF; Jorge AA; Pinto EM; Arnhold IJ; Mendonca BB; Nishi MY
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1382-7. PubMed ID: 19169498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel class of Pseudoautosomal region 1 deletions downstream of SHOX is associated with Leri-Weill dyschondrosteosis.
    Benito-Sanz S; Thomas NS; Huber C; Gorbenko del Blanco D; Aza-Carmona M; Crolla JA; Maloney V; Rappold G; Argente J; Campos-Barros A; Cormier-Daire V; Heath KE
    Am J Hum Genet; 2005 Oct; 77(4):533-44. PubMed ID: 16175500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHOX gene defects and selected dysmorphic signs in patients of idiopathic short stature and Léri-Weill dyschondrosteosis.
    Hirschfeldova K; Solc R; Baxova A; Zapletalova J; Kebrdlova V; Gaillyova R; Prasilova S; Soukalova J; Mihalova R; Lnenicka P; Florianova M; Stekrova J
    Gene; 2012 Jan; 491(2):123-7. PubMed ID: 22020182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mosaic compound heterozygosity of SHOX resulting in Leri-Weill dyschondrosteosis with marked short stature: implications for disease mechanisms and recurrence risks.
    Reish O; Huber C; Altarescu G; Chapman-Shimshoni D; Levy-Lahad E; Renbaum P; Mashevich M; Munnich A; Cormier-Daire V
    Am J Med Genet A; 2010 Sep; 152A(9):2230-5. PubMed ID: 20683993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the first recurrent PAR1 deletion in Léri-Weill dyschondrosteosis and idiopathic short stature reveals the presence of a novel SHOX enhancer.
    Benito-Sanz S; Royo JL; Barroso E; Paumard-Hernández B; Barreda-Bonis AC; Liu P; Gracía R; Lupski JR; Campos-Barros Á; Gómez-Skarmeta JL; Heath KE
    J Med Genet; 2012 Jul; 49(7):442-50. PubMed ID: 22791839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the first PAR1 deletion encompassing upstream SHOX enhancers in a family with idiopathic short stature.
    Benito-Sanz S; Aza-Carmona M; Rodríguez-Estevez A; Rica-Etxebarria I; Gracia R; Campos-Barros A; Heath KE
    Eur J Hum Genet; 2012 Jan; 20(1):125-7. PubMed ID: 22071895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a major recombination hotspot in patients with short stature and SHOX deficiency.
    Schneider KU; Sabherwal N; Jantz K; Röth R; Muncke N; Blum WF; Cutler GB; Rappold G
    Am J Hum Genet; 2005 Jul; 77(1):89-96. PubMed ID: 15931595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SHOX gene deletion screening by FISH in children with short stature and Madelung deformity and their characteristics.
    Kurnaz E; Savaş-Erdeve Ş; Çetinkaya S; Aycan Z
    J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1273-1278. PubMed ID: 30332396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic molecular analyses of SHOX in Japanese patients with idiopathic short stature and Leri-Weill dyschondrosteosis.
    Shima H; Tanaka T; Kamimaki T; Dateki S; Muroya K; Horikawa R; Kanno J; Adachi M; Naiki Y; Tanaka H; Mabe H; Yagasaki H; Kure S; Matsubara Y; Tajima T; Kashimada K; Ishii T; Asakura Y; Fujiwara I; Soneda S; Nagasaki K; Hamajima T; Kanzaki S; Jinno T; Ogata T; Fukami M;
    J Hum Genet; 2016 Jul; 61(7):585-91. PubMed ID: 26984564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative real-time polymerase chain reaction (RQ-PCR) for the rapid detection of SHOX haploinsufficiency in Leri-Weill Syndrome.
    Tan YM; Loke KY
    Diagn Mol Pathol; 2005 Dec; 14(4):247-9. PubMed ID: 16319696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different approaches in the molecular analysis of the SHOX gene dysfunctions.
    Stuppia L; Gatta V; Antonucci I; Giuliani R; Palka G
    J Endocrinol Invest; 2010 Jun; 33(6 Suppl):30-3. PubMed ID: 21057183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the first de novo PAR1 deletion downstream of SHOX in an individual diagnosed with Léri-Weill dyschondrosteosis (LWD).
    Barroso E; Benito-Sanz S; Belinchón A; Yuste-Checa P; Gracia R; Aragones A; Campos-Barros A; Heath KE
    Eur J Med Genet; 2010; 53(4):204-7. PubMed ID: 20412871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular characterization of Chilean patients with Léri-Weill dyschondrosteosis.
    Rodríguez FA; Unanue N; Hernandez MI; Basaure J; Heath KE; Cassorla F
    J Pediatr Endocrinol Metab; 2013; 26(7-8):729-34. PubMed ID: 23729538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.